Biological and Therapeutic Advances in the Pursuit of Effective Immunotherapy for Prostate Cancer

Anis A. Hamid; Atish D. Choudhury


Curr Opin Urol. 2020;30(1):30-35. 

In This Article


Continued efforts to develop novel therapeutic immune-targeting agents and test rational combinations in the clinic, hold the promise of improving the efficacy of immunotherapy across the clinical spectrum of prostate cancer. In parallel, there is a clear unmet need to better understand the complexity of the prostate cancer immune microenvironment as well as train and validate predictive biomarkers to improve the precision of patient selection for existing and novel therapies. Both efforts will necessarily inform each other in the pursuit of effective and biomarker-driven immunotherapy for prostate cancer.